Physiological Effect: Decreased Cholesterol Absorption
✉ Email this page to a colleague
Drugs with Physiological Effect: Decreased Cholesterol Absorption
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hetero Labs Ltd Iii | EZETIMIBE | ezetimibe | TABLET;ORAL | 210859-001 | Jul 26, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sandoz | EZETIMIBE | ezetimibe | TABLET;ORAL | 203931-001 | Jun 12, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Macleods Pharms Ltd | EZETIMIBE | ezetimibe | TABLET;ORAL | 211159-001 | Apr 29, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alkem Labs Ltd | EZETIMIBE | ezetimibe | TABLET;ORAL | 209234-001 | Dec 21, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Glenmark Pharms Ltd | EZETIMIBE | ezetimibe | TABLET;ORAL | 078560-001 | Jun 26, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Orient Pharma | EZETIMIBE | ezetimibe | TABLET;ORAL | 215693-001 | Sep 13, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ohm Labs Inc | EZETIMIBE | ezetimibe | TABLET;ORAL | 207311-001 | Jun 12, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
